{"id":249477,"date":"2026-07-08T11:00:00","date_gmt":"2026-07-08T15:00:00","guid":{"rendered":"https:\/\/ibkrcampus.com\/campus\/?p=249477"},"modified":"2026-07-08T11:16:38","modified_gmt":"2026-07-08T15:16:38","slug":"summer-rotation-why-healthcare-stocks-often-take-the-lead-in-q3","status":"publish","type":"post","link":"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/stocks\/summer-rotation-why-healthcare-stocks-often-take-the-lead-in-q3\/","title":{"rendered":"Summer Rotation: Why Healthcare Stocks Often Take the Lead in Q3"},"content":{"rendered":"\n

Technology stocks often dominate the headlines during the first half of the year. Yet, once July arrives, history suggests leadership frequently begins to rotate. So, instead of chasing the year\u2019s biggest winners, institutional investors have often shifted toward sectors offering more predictable earnings and <\/em>defensive characteristics.

Healthcare has historically been one of those sectors.<\/p>\n\n\n\n

UnitedHealth Shows July Seasonality<\/strong><\/h3>\n\n\n\n

The chart below shows that over the last 15 years, UnitedHealth (UNH) has produced an average return of +2.43% from 8 July to 23 July, with a 73.33% win rate and an annualized return of +78.69%.<\/p>\n\n\n\n

\"UnitedHealth
UnitedHealth\u2019s seasonal window has delivered gains in 11 of the past 15 years. Source: Seasonax<\/a> | View pattern<\/a><\/figcaption><\/figure>\n\n\n\n

Perhaps most encouraging is the pattern distribution. Eleven of the past fifteen years have delivered gains during this seasonal window, while the cumulative profit curve has steadily risen over time, suggesting this has been a consistent period of strength rather than one driven by only a handful of exceptional years.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Johnson & Johnson Adds Further Confirmation<\/strong><\/h3>\n\n\n\n

A very similar the seasonal tendency can also be seen in one of healthcare\u2019s most established companies. Johnson & Johnson is one of the world\u2019s largest healthcare companies, developing and selling a broad range of prescription medicines and medical technologies used to treat millions of patients every year.<\/p>\n\n\n\n

The chart below shows that over the last 15 years, Johnson & Johnson has returned an average of +2.66% between 30 June and 29 July, producing gains in 73.33% of observations and an annualized return of +39.21%.<\/p>\n\n\n\n

\"Johnson
Johnson & Johnson confirms the same seasonal window seen in UNH. Source:\u00a0Seasonax<\/a>\u00a0|\u00a0View pattern<\/a><\/figcaption><\/figure>\n\n\n\n

Once again, the cumulative profit curve trends consistently higher, reinforcing the view that this is a recurring seasonal phenomenon across multiple healthcare names rather than an isolated company-specific event.<\/p>\n\n\n\n

So, Why Do Healthcare Names Often Strengthen During July?<\/strong><\/h3>\n\n\n\n

Several factors may help explain this recurring seasonal tendency.<\/p>\n\n\n\n

Following the first-half rally, portfolio managers often rebalance away from higher-beta sectors into businesses offering more stable earnings visibility. Healthcare naturally benefits from this shift. Unlike many cyclical sectors, demand for healthcare products and services remains relatively stable regardless of economic conditions. Investors often become more selective during the quieter summer months, favouring companies with predictable cash flows and resilient earnings. At the same time, long-term structural themes continue to support the sector.<\/p>\n\n\n\n

According to Reuters GLP-1 obesity and diabetes treatments continue to reshape the pharmaceutical industry, while innovation in oncology, immunology, and medical devices remains a major source of long-term growth.<\/p>\n\n\n\n

These drivers likely provide an additional layer of support beyond the seasonal pattern itself.<\/p>\n\n\n\n

Trade Risks and Opportunities<\/strong><\/h3>\n\n\n\n

Now, no seasonal tendency is guaranteed and this is no exception. Some major potential headwinds include:<\/p>\n\n\n\n